Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanneke van der Gulden

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|April 10, 2004
Characterization and functional analysis of the murine Frat2 geneRenée van Amerongen, Hanneke van der Gulden, Fonnet Bleeker, et al.
The Journal of Pathology|December 13, 2016
Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in miceMarieke van de Ven, Eline van der Burg, Hanneke van der Gulden, et al.
Genes & Development|February 1, 2005
Frat is dispensable for canonical Wnt signaling in mammalsRenée van Amerongen, Martijn Nawijn, Jonathan Franca-Koh, et al.
The Journal of Pathology|March 16, 2011
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppressionPeter Bouwman, Rinske Drost, Christiaan Klijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Functional Categorization of <i>BRCA1</i> Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.
Cancer Discovery|July 23, 2013
A high-throughput functional complementation assay for classification of BRCA1 missense variantsPeter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancerXiaoling Liu, Henne Holstege, Hanneke van der Gulden, et al.
Cancer Cell|November 14, 2006
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisPatrick W B Derksen, Xiaoling Liu, Francis Saridin, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Genome Biology|October 15, 2010
Somatic structural rearrangements in genetically engineered mouse mammary tumorsIgnacio Varela, Christiaan Klijn, Phillip J Stephens, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|April 10, 2004
Characterization and functional analysis of the murine Frat2 geneRenée van Amerongen, Hanneke van der Gulden, Fonnet Bleeker, et al.
The Journal of Pathology|December 13, 2016
Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in miceMarieke van de Ven, Eline van der Burg, Hanneke van der Gulden, et al.
Genes & Development|February 1, 2005
Frat is dispensable for canonical Wnt signaling in mammalsRenée van Amerongen, Martijn Nawijn, Jonathan Franca-Koh, et al.
The Journal of Pathology|March 16, 2011
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppressionPeter Bouwman, Rinske Drost, Christiaan Klijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Functional Categorization of <i>BRCA1</i> Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.
Cancer Discovery|July 23, 2013
A high-throughput functional complementation assay for classification of BRCA1 missense variantsPeter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancerXiaoling Liu, Henne Holstege, Hanneke van der Gulden, et al.
Cancer Cell|November 14, 2006
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisPatrick W B Derksen, Xiaoling Liu, Francis Saridin, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Genome Biology|October 15, 2010
Somatic structural rearrangements in genetically engineered mouse mammary tumorsIgnacio Varela, Christiaan Klijn, Phillip J Stephens, et al.
Pageof 2